Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/02/2009 | WO2009081222A1 Substituted tricyclic pyridine or pyrimidine vanilloid receptor ligands |
07/02/2009 | WO2009081219A1 Quinazoline derivatives as vanilloid receptor modulators |
07/02/2009 | WO2009081087A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
07/02/2009 | WO2009016387A3 Process for the preparation of alfuzosin hydrochloride |
07/02/2009 | WO2009012375A3 Squarate kinase inhibitors |
07/02/2009 | US20090171086 2,4-pyrimidinediamine compounds and their uses |
07/02/2009 | US20090171085 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
07/02/2009 | US20090170922 Benzimidazole derivatives and their use as a medicament |
07/02/2009 | US20090170905 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
07/02/2009 | US20090170903 Ester derivatives as phosphodiesterase inhibitors |
07/02/2009 | US20090170902 Compounds which potentiate glutamate receptor and uses thereof in medicine |
07/02/2009 | US20090170894 Urea derivatives of tropane, their preparation and their therapeutic application |
07/02/2009 | US20090170881 New inhibitors of histone deacetylase |
07/02/2009 | US20090170870 Amidine-containing compounds useful as muscarinic receptor antagonists |
07/02/2009 | US20090170869 Piperazine derivative having affinity for the histamine h3 receptor |
07/02/2009 | US20090170859 Viral Polymerase Inhibitors |
07/02/2009 | US20090170852 NOVEL PYRAZOLE-BASED HMG CoA REDUCTASE INHIBITORS |
07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
07/02/2009 | US20090170835 Isoindoline derivatives |
07/02/2009 | US20090170829 Carboxamide, Sulfonamide and Amine Compounds and Methods for Using The Same |
07/02/2009 | US20090170814 Neurodegenerative disorders; antiinflammatory agents; antiischemic agents; neuropathic pain; antiepileptic agents; Parkinson's disease; Alzheimer's disease; antidiabetic agents; 3-(6-Hydroxy-2-methyl-3,4,7,8,9,10-hexahydro-7,10-methano-2H -benzo[h]chromen-2-yl)-propionic acid methyl ester |
07/02/2009 | US20090167165 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device |
07/02/2009 | US20090167162 Dibenzothiophene-containing materials in phosphorescent light emitting diodes |
07/02/2009 | CA2706372A1 Crystalline polymorph of doxazosin mesylate (form iv) and process for preparation thereof |
07/01/2009 | EP2075250A2 Thrombin receptor antagonists |
07/01/2009 | EP2074116A2 Process for preparing trityl olmesartan medoxomil and olmesartan medoxomil |
07/01/2009 | EP2074115A1 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors |
07/01/2009 | EP2074114A1 Pyrimidinones as casein kinase ii (ck2) modulators |
07/01/2009 | EP2074108A1 Renin inhibitors |
07/01/2009 | EP2074107A2 Tricyclic compounds as matrix metalloproteinase inhibitors |
07/01/2009 | EP2074106A1 Dibenzofuran derivatives as inhibitors of pde-4 and pde-10 |
07/01/2009 | EP2074093A2 Matrix metalloproteinase inhibitors |
07/01/2009 | EP2074089A2 Organic compounds |
07/01/2009 | EP2074086A1 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
07/01/2009 | EP2074084A1 Compounds which modulate the cb2 receptor |
07/01/2009 | EP2073799A2 Novel agents of calcium ion channel modulators |
07/01/2009 | EP1861365B1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
07/01/2009 | EP1784393B1 Quinazolines useful as modulators of ion channels |
07/01/2009 | EP1776339B1 3-(((4-phenyl)-piperazin-1-yl)-alkyl)-3-alkyl-1,3-dihydro-2h-indol-2-one derivatives and related compounds for the treatment of central nervous system disorders |
07/01/2009 | EP1697343B1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
07/01/2009 | EP1691810A4 Substituted piperazines |
07/01/2009 | EP1682126B1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
07/01/2009 | EP1611104B1 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
07/01/2009 | CN101472919A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
07/01/2009 | CN101472918A Azolylmethyloxiranes, their use for controlling phytopathogenic fungi and compositions comprising them |
07/01/2009 | CN101472917A Benzimidazole 5-sulfonamide derivatives as cannabinoid 1 (CB1) receptor ligands |
07/01/2009 | CN101469009A Methods and compositions for treating hepatitis c virus |
07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
07/01/2009 | CN100506807C Amide derivatives as GK activators |
07/01/2009 | CN100506801C Inhibitors of glycogen synthase kinase 3 |
07/01/2009 | CN100506792C Substituted N-arylheterocycles, method for production and use thereof as medicaments |
06/30/2009 | US7553976 Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
06/30/2009 | US7553972 Benzamide inhibitors of the P2X7 receptor |
06/30/2009 | US7553971 Aryl aniline β2 adrenergic receptor agonists |
06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
06/30/2009 | US7553848 Vanilloid receptor ligands and their use in treatments |
06/30/2009 | US7553841 Amino cyclobutylamide modulators of chemokine receptor activity |
06/30/2009 | US7553837 Phenylazole compounds production process and antioxidants |
06/30/2009 | CA2510964C Therapeutic phenoxyalkylfurans and intermediates therefor |
06/25/2009 | WO2009079624A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
06/25/2009 | WO2009079547A1 Quinazoline anhydrate forms |
06/25/2009 | WO2009079541A1 Quinazoline ditosylate anhydrate forms |
06/25/2009 | WO2009079391A1 Benzofuran anilide histone deacetylase inhibitors |
06/25/2009 | WO2009078588A2 Composition for prevention and treatment of cancer containing pyrimidine derivatives inhibiting activity of protein phosphatases or pharmaceutically acceptable salts thereof as an active ingredient |
06/25/2009 | WO2009077574A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
06/25/2009 | WO2009077500A2 Azolylmethyloxiranes, use thereof and agents containing the same |
06/25/2009 | WO2009077068A1 Ester derivatives as phosphodiesterase inhibitors |
06/25/2009 | WO2009077059A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates |
06/25/2009 | WO2009076693A1 Octahydroquinoli zines for antidiabetic treatment |
06/25/2009 | WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors |
06/25/2009 | US20090163683 Photopolymerizable monomers having epoxide and unsaturated double bonds and their composition |
06/25/2009 | US20090163560 5-(3-(2-(4-(1-Hydroxyhexyl)phenyl)-3-oxopyrazolidin-1-yl)propyl)thiophene-2-carboxylic acid; bioisosteres; vision defects; glaucoma; hypotensive agents; ocular hypertension; kits |
06/25/2009 | US20090163549 Pharmaceutical Composition Comprising an Amide Derivative |
06/25/2009 | US20090163518 Novel Compounds |
06/25/2009 | US20090163515 Compounds Which Bind to the Active Site of Protein Kinase Enzymes |
06/25/2009 | US20090163502 Tetrazole-substituted arylamides as P2X3 and P2X2/3 antagonists |
06/25/2009 | US20090163498 Aryl Sulfonamides |
06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
06/25/2009 | US20090163493 cell proliferation, such as cancer, inflammation, and angiogenesis; fungal infections; antimalaria; Heat hock protein 90 (HSP-90) inhibitor |
06/25/2009 | US20090163477 Phthalazinone derivatives |
06/25/2009 | US20090162433 Method of treatment |
06/25/2009 | US20090159841 Recovery of Optically Active Epoxy Alcohols |
06/25/2009 | DE102007061757A1 Substituierte 2-Phenylpyrimidin-5-carbonsäuren und ihre Verwendung Substituted 2-phenyl-pyrimidine-5-carboxylic acids and their use |
06/25/2009 | CA2710006A1 Octahydroquinoli zines for antidiabetic treatment |
06/25/2009 | CA2709186A1 4-imidazolidinones as kv1.5 potassium channel inhibitors |
06/25/2009 | CA2709068A1 Benzofuran anilide histone deacetylase inhibitors |
06/24/2009 | EP2072515A1 Substituted quinazolidines for antidiabetic treatment |
06/24/2009 | EP1948654B1 5-amino-4-hydroxy-7- (imidazo [1,2-a] pyridin-6- ylmethyl)-8-methyl-nonamide derivatives and related compounds as renin inhibitors for the treatment of hypertension |
06/24/2009 | EP1763526B1 4,6-disubstituted pyrimidines and their use as protein kinase inhibitors |
06/24/2009 | EP1611109A4 Novel quinazoline derivatives and methods of treatment related to the use thereof |
06/24/2009 | EP1445258B1 Activator for peroxisome proliferator-activated receptor delta |
06/24/2009 | CN101466707A Pyrrolidine derivatives useful against diseases that depend on activity of renin |
06/24/2009 | CN101466706A Dual molecules containing a peroxide derivative, their synthesis and therapeutic uses |
06/24/2009 | CN101466705A Substituted enaminocarbonyl compounds |
06/24/2009 | CN101466704A Fused ring thrombin receptor antagonists |
06/24/2009 | CN101466686A C-FMS kinase inhibitor |
06/24/2009 | CN100503603C Chroman compound and its preparing method and use in producing medicine |
06/24/2009 | CN100503602C Benzopyran derivatives substituted with secondary amines including tetrazole, method for the preparation thereof and pharmaceutical compositions containing them |
06/24/2009 | CN100503600C Pesticidal heterocycles |